Precision BioSciences Announces Data Presentation on Effective Cell Dose and Functional Attributes of CD19 Allogeneic CAR T, Azer-Cel, at the Upcoming 2022 American Society of Hematology (ASH) Annual MeetingBusiness Wire • 11/03/22
Precision BioSciences to Report Third Quarter 2022 Financial Results on November 8, 2022Business Wire • 11/02/22
Precision BioSciences Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)Business Wire • 10/26/22
Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th CongressBusiness Wire • 10/11/22
Precision BioSciences to Participate in Upcoming Jefferies Cell & Genetic Medicine SummitBusiness Wire • 09/22/22
Precision BioSciences to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment ConferenceBusiness Wire • 09/07/22
Precision BioSciences (DTIL) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/08/22
Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business UpdateBusiness Wire • 08/08/22
Precision BioSciences to Report Second Quarter 2022 Financial Results on August 8, 2022Business Wire • 08/01/22
All You Need to Know About Precision BioSciences (DTIL) Rating Upgrade to Strong BuyZacks Investment Research • 07/21/22
Precision BioSciences Announces Closing of Underwritten Offering of Common StockBusiness Wire • 06/27/22
Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including Sickle Cell DiseaseBusiness Wire • 06/21/22
Precision BioSciences Provides Update on Allogeneic CAR T Programs and Path Forward with Its Lead PBCAR0191 Candidate for CAR T Relapsed Patient PopulationBusiness Wire • 06/08/22
Precision BioSciences to Provide an Update on its Ongoing Allogeneic CAR T Programs via Hosted Virtual Webcast and Conference Call on Wednesday, June 8, 2022Business Wire • 06/03/22
Precision BioSciences to Participate in Upcoming Jefferies Healthcare ConferenceBusiness Wire • 06/03/22